Promising new cholesterol drug gains initial FDA approval

[KARE 11, June 10, 2015] An FDA advisory group has approved two new cholesterol drugs that appear to be more effective than current drugs, and have fewer side effects. Preventive cardiologist Dr. Michael Miedema, from the Minneapolis Heart Institute at Abbott Northwestern Hospital, talked to KARE 11 News about the new drugs.

Share this article